Categories: Wire Stories

Eurofins Enhances Clinical and COVID-19 Testing Offering in Japan Through Acquisition of Genetic Lab Co.,Ltd.

LUXEMBOURG–(BUSINESS WIRE)–Eurofins Scientific (EUFI.PA), the global scientific leader in bioanalytical testing and a leader in clinical diagnostics testing, announces a share purchase agreement with Transgenic Inc. (2342:JP, Tokyo stock exchange) to acquire Genetic Lab Co.,Ltd. (“G Lab”), a molecular biology based testing provider for diagnostics, biomarker development and drug discovery. The acquisition will further enhance Eurofins’ expansion in Asia and complement its global network of clinical diagnostics laboratories focused on specialised and advanced genetic testing.

G Lab employs over 70 staff and generated revenues of over EUR 13m in the financial year ending March 2021. Initially established as a genetics technology based bio venture in 2000, G Lab has developed a reputation among clinical communities in Japan for the CAP accredited quality services provided by its technical experts, in-house medical pathologists and cytotechnologists. G Lab also provides diversified testing services supporting biomarker development for companion drugs. Since Mar 2020, G Lab has played an important role in the COVID-19 response in Japan, by facilitating PCR testing, and supporting Hokkaido prefecture and Sapporo city with their COVID-19 testing programmes

Through this acquisition, the Eurofins network will further strengthen its position in the Japanese market, where it is currently the market leader in environment testing and non-invasive prenatal testing, by extending its service offering in BioPharma services and clinical testing in Japan, notably increasing its COVID-19 testing product and service offering to support the fight against the pandemic.

Notes to Editors:

For more information, please visit www.eurofins.com.

About Eurofins – the global leader in bio-analysis

Eurofins is Testing for Life. With 55,000 staff across a network of 900 laboratories in over 50 countries, Eurofins’ companies offer a portfolio of over 200,000 analytical methods.

Eurofins Shares are listed on Euronext Paris Stock Exchange.

Contacts

Investor Relations

Eurofins Scientific SE

Yuya Kusunoki

+32 2 766 1620

ir@eurofins.com

Alex

Alex is a writer and digital content enthusiast who enjoys covering technology, current trends, useful tips, and topics that matter to everyday readers. With a focus on clear, informative, and easy-to-understand content, Alex aims to provide readers with practical insights and interesting perspectives across a wide range of subjects.

Recent Posts

iPad mini: what Apple’s biggest update means for the pocketable tablet

Key takeaways:Headlines call this the biggest iPad mini update ever, but they disagree on whether…

19 minutes ago

Gareth Batty Joins Chennai Super Kings as Assistant Coach After Leaving Surrey

Key takeaways:Gareth Batty has officially stepped down as Surrey head coach to join Chennai Super…

48 minutes ago

Sudurpaschim Royals vs Lumbini Lions: NPL fixture date, 2025 final context and live-watch details

Key takeaways:Sudurpaschim Royals vs Lumbini Lions is listed as the 1st match of Nepal Premier…

1 hour ago

Mohun Bagan vs Chennaiyin FC: ISL Match Preview, Budget Contrast, and Live Streaming Details

Key takeaways:Mohun Bagan Super Giant enter their ISL-13 home opener against Chennaiyin FC taking a…

2 hours ago

Lumbini Lions vs Sudurpaschim Royals: Matches, Coverage, and 2026 Fixture (Nepal Premier League)

Key takeaways:Lumbini Lions (LUL) and Sudurpaschim Royals (SPR) played the 13th match of the Nepal…

2 hours ago

Former DMK Minister Anbil Mahesh Poyyamozhi Arrested in ₹100-Crore Private Schools Scam

Key takeaways:Former DMK Minister Anbil Mahesh Poyyamozhi was arrested by authorities in Chennai.The arrest relates…

3 hours ago